Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (48)

2024

  1. Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis

    Medicina Clinica, Vol. 162, Núm. 7, pp. e1-e7

  2. Predicting the development of heart failure in patients with atrial fibrillation

    Revista Espanola de Cardiologia

  3. Prognostic impact of chronic obstructive pulmonary disease and bronchial asthma in patients with heart failure

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 123-132

  4. Prognostic value of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in cardiac amyloidosis

    Revista Espanola de Cardiologia

  5. Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin

    Frontiers in Cardiovascular Medicine, Vol. 11

  6. Review of the allocation criteria for heart transplant in Spain in 2023. SEC-Heart Failure Association/ONT/SECCE consensus document

    Revista Espanola de Cardiologia, Vol. 77, Núm. 1, pp. 69-78

  7. Use of SGLT2i in patients with transthyretin amyloid cardiomyopathy: prevalence and safety in a Spanish prospective cohort

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 349-352

  8. Use of a surgically implanted, nondischargeable, extracorporeal continuous flow circulatory support system as a bridge to heart transplant

    Revista espanola de cardiologia (English ed.), Vol. 77, Núm. 1, pp. 39-49

2023

  1. Clinical outcomes in heart transplant recipients with coronary abnormalities in the donor graft

    Revista Espanola de Cardiologia, Vol. 76, Núm. 6, pp. 473-474

  2. Current situation of the comprehensive approach of heart failure in Spain. The OPTIMISE-IC project

    REC: CardioClinics, Vol. 58, Núm. 4, pp. 289-302

  3. Durable ventricular assist device in Spain (2007-2020). First report of the REGALAD registry

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 227-237

  4. Mechanical circulatory support in severe primary graft dysfunction: Peripheral cannulation but not earlier implantation improves survival in heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 42, Núm. 8, pp. 1101-1111

  5. Mortality After the First Hospital Admission for Acute Heart Failure, De Novo Versus Acutely Decompensated Heart Failure With Reduced Ejection Fraction

    American Journal of Cardiology, Vol. 196, pp. 59-66

  6. Prevalence, Characteristics, and Prognostic Relevance of Donor-Transmitted Coronary Artery Disease in Heart Transplant Recipients

    Journal of the American College of Cardiology, Vol. 82, Núm. 9, pp. 753-767

  7. Sex, Temporary Mechanical Circulatory Support, and Heart Transplantation: Insights From a Multi-Institutional Spanish Registry

    JACC: Heart Failure

  8. Soluble HLA-G levels in heart transplant recipients: Dynamics and correlation with clinical outcomes

    Transplant Immunology, Vol. 76

  9. Survival impact of previous statin therapy in patients hospitalized with COVID-19

    Medicina Clinica, Vol. 160, Núm. 1, pp. 1-9

  10. Temporal trends in the use and outcomes of temporary mechanical circulatory support as a bridge to cardiac transplantation in Spain. Final report of the ASIS-TC study

    Journal of Heart and Lung Transplantation, Vol. 42, Núm. 4, pp. 488-502

  11. Use of a surgically implanted, nondischargeable, extracorporeal continuous flow circulatory support system as a bridge to heart transplant

    Revista Espanola de Cardiologia

2022

  1. Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy

    Mayo Clinic Proceedings, Vol. 97, Núm. 2, pp. 261-273